Cargando…

No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity

INTRODUCTION: Convalescent plasma transfusion (CPT), a potential therapy for coronavirus disease 2019 (COVID-19), requires strict quality control of the donor blood. Whether to confirm the disappearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA (RNAemia) in convalescent don...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomoto, Hidetoshi, Kutsuna, Satoshi, Okuma, Kazu, Kuramitsu, Madoka, Tezuka, Kenta, Ikebe, Emi, Saito, Sho, Kinoshita, Noriko, Terada, Mari, Endo, Mio, Suzuki, Tetsuya, Miyazato, Yusuke, Nakamoto, Takato, Inada, Makoto, Hamaguchi, Isao, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836836/ https://www.ncbi.nlm.nih.gov/pubmed/33487533 http://dx.doi.org/10.1016/j.jiac.2021.01.004

Ejemplares similares

Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor
por: Tezuka, Kenta, et al.
Publicado: (2018)

Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
por: Kutsuna, Satoshi, et al.
Publicado: (2021)

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial
por: Saito, Sho, et al.
Publicado: (2023)

Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan
por: Suzuki, Tetsuya, et al.
Publicado: (2022)

Hemoptysis and a Newly Formed Lung Bulla in a Case of Convalescent COVID-19 Pneumonia
por: Sato, Lubna, et al.
Publicado: (2021)

Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019
por: Nomoto, Hidetoshi, et al.
Publicado: (2020)

Correction: Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019
por: Nomoto, Hidetoshi, et al.
Publicado: (2022)

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Cytolytic Recombinant Vesicular Stomatitis Viruses Expressing STLV-1 Receptor Specifically Eliminate STLV-1 Env-Expressing Cells in an HTLV-1 Surrogate Model In Vitro
por: Seki, Yohei, et al.
Publicado: (2022)

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma
por: Inada, Makoto, et al.
Publicado: (2023)

Performance evaluation of in vitro diagnostic kits for hepatitis B virus infection using the regional reference panel of Japan
por: Momose, Haruka, et al.
Publicado: (2023)

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers()
por: Suzuki, Tetsuya, et al.
Publicado: (2021)

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
por: Tomita, Noriko, et al.
Publicado: (2022)

Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity
por: Nakamura, Keiji, et al.
Publicado: (2020)

7. Clinical outcomes and epidemiological characteristics of bacteremia in the older population of Japan
por: Nakamura, Keiji, et al.
Publicado: (2021)

Acute portal vein thrombosis with COVID-19 and cirrhosis
por: Miyazato, Yusuke, et al.
Publicado: (2021)

Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo
por: Hiyoshi, Masateru, et al.
Publicado: (2015)

Frequent horizontal and mother-to-child transmission may contribute to high prevalence of STLV-1 infection in Japanese macaques
por: Murata, Megumi, et al.
Publicado: (2020)

Clinical course of alopecia after COVID-19
por: Suzuki, Tetsuya, et al.
Publicado: (2021)

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants
por: Tsuchiya, Kiyoto, et al.
Publicado: (2023)

Residual and Late Onset Symptoms Appeared in a Patient with Severe Fever with Thrombocytopenia in a Convalescence Stage
por: Kanda, Kohei, et al.
Publicado: (2021)

Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital
por: Morioka, Shinichiro, et al.
Publicado: (2020)

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
por: Miyazato, Yusuke, et al.
Publicado: (2020)

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Leuconostoc lactis and Staphylococcus nepalensis Bacteremia, Japan
por: Hosoya, Satoshi, et al.
Publicado: (2020)

A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
por: Maeda, Kenji, et al.
Publicado: (2021)

Clinical performance testing of the automated haematology analyzer XN-31 prototype using whole blood samples from patients with imported malaria in Japan
por: Komaki-Yasuda, Kanako, et al.
Publicado: (2022)

Periungual desquamation in a Japanese Adult recovering from severe COVID-19
por: Nakamoto, Takato, et al.
Publicado: (2021)

Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan
por: Akiyama, Yutaro, et al.
Publicado: (2020)

Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19
por: Sugiyama, Masaya, et al.
Publicado: (2021)

Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease
por: Okuhama, Ayako, et al.
Publicado: (2022)

Surveillance and risk assessment of health screening for vaccine-preventable diseases among international students in Japan: A cross-sectional study in 2020
por: Takahata, Hanako, et al.
Publicado: (2022)

201. Characteristics of Streptococcal Toxic Shock Syndrome Caused by Different Beta-Hemolytic Streptococci Species: A Single-Center Retrospective Study
por: Inada, Makoto, et al.
Publicado: (2023)

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan
por: Fujino, Takahisa, et al.
Publicado: (2021)

Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

1182. Risk Factors for the Acquisition of IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case–control Study
por: Saito, Sho, et al.
Publicado: (2018)

1193. Comparison of the Clinical Outcomes of Patients With IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenem-Sensitive Enterobacteriaceae in Japan
por: Saito, Sho, et al.
Publicado: (2018)

Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies
por: Inada, Makoto, et al.
Publicado: (2021)

Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019
por: Ide, Satoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ihc94s85p6r4uubu0e1co4rsto